Goldin Lynn R, Landgren Ola
Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892-7236, USA.
Int J Cancer. 2009 Apr 1;124(7):1497-502. doi: 10.1002/ijc.24141.
For more than 50 years, links between autoimmunity and lymphomas have been described based on human and animal studies. Over the last 3 decades, many studies have addressed specific hypotheses about these associations using population level data. This has been accomplished by assessing previous autoimmune history in case-control studies of patients with lymphoma (mainly non-Hodgkin lymphoma) and myeloma, and by following cohorts of patients with various autoimmune diseases for subsequent development of lymphoma and multiple myeloma. In this article, we review our recently published series of association studies based on data from Scandinavia and from US Veterans and other relevant findings. We also discuss what these associations have revealed about the mechanisms and pathways underlying both autoimmunity and lymphoma. Finally, we discuss the future directions involving a combination of population and molecular studies that are needed to better define underlying biological mechanisms.
五十多年来,基于人类和动物研究,自身免疫与淋巴瘤之间的联系已被描述。在过去三十年中,许多研究使用人群水平数据探讨了关于这些关联的特定假设。这是通过在淋巴瘤(主要是非霍奇金淋巴瘤)和骨髓瘤患者的病例对照研究中评估既往自身免疫病史,以及对患有各种自身免疫性疾病的患者队列进行随访以观察随后淋巴瘤和多发性骨髓瘤的发生来实现的。在本文中,我们基于来自斯堪的纳维亚半岛、美国退伍军人的数据以及其他相关发现,回顾我们最近发表的一系列关联研究。我们还讨论了这些关联揭示了自身免疫和淋巴瘤背后的机制及途径。最后,我们讨论了未来方向,涉及需要结合人群和分子研究以更好地确定潜在生物学机制。